This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Viemann, M. Articles by Sippell, W. G. Search for Related Content PubMed PubMed Citation Articles by Viemann, M. Articles by Sippell, W. G.

Evidence for Genetic Heterogeneity of Pseudohypoaldosteronism Type 1: Identification of a Novel Mutation in the Human Mineralocorticoid Receptor in one Sporadic Case and No Mutations in Two Autosomal Dominant Kindreds

Division of Pediatric Endocrinology, Department of Pediatrics, Christian Albrechts University of Kiel (M.V., M.P., W.G.S.), D-24105 Kiel, Germany; SANITAS Ostseeklinik Boltenhagen (M.P.), D-23946 Boltenhagen, Germany; Children’s Hospital of Málaga (J.P.L.-S.), E-20911 Málaga, Spain; and Children’s Hospital of Bremen-Nord (G.S.-S.), D-28755 Bremen, Germany

Address all correspondence and requests for reprints to: Prof. W. G. Sippell, M.D., Division of Pediatric Endocrinology, Department of Pediatrics, Schwanenweg 20, Universitäts Kinderklinik, D-24105 Kiel, Germany. E-mail: sippell{at}pediatrics.uni-kiel.de

Pseudohypoaldosteronism type 1 (PHA1) is characterized by neonatal salt wasting resistant to mineralocorticoids. There are 2 forms of PHA1: the autosomal recessive form with symptoms persisting into adulthood, caused by mutations in the amiloride-sensitive luminal sodium channel, and the autosomal dominant or sporadic form, which shows milder symptoms that remit with age. Mutations in the gene encoding the human mineralocorticoid receptor (hMR) are, at least in some patients, responsible for the latter form of PHA1. We here report the results of a genetic study in a sporadic case and in 5 affected patients from 2 families with autosomal dominant PHA1. In the sporadic case we identified a new frameshift mutation, Ins2871C, in exon 9 of the hMR gene. Family members were asymptomatic and had no mutation. This mutation is the first described in exon 9 and impairs the last 27 amino acids of the hormone-binding domain. In 2 kindreds with autosomal dominant PHA1 we found no mutation of the hMR gene. Our results confirm the hypothesis that autosomal dominant or sporadic PHA1 is a genetically heterogeneous disease involving other, as yet unidentified, genes.

This article has been cited by other articles:

				A. Balsamo, A. Cicognani, M. Gennari, W. G Sippell, S. Menabo, F. Baronio, and F. G Riepe Functional characterization of naturally occurring NR3C2 gene mutations in Italian patients suffering from pseudohypoaldosteronism type 1 Eur. J. Endocrinol., February 1, 2007; 156(2): 249 - 256. [Abstract] [Full Text] [PDF]

				F. G. Riepe, J. Finkeldei, L. de Sanctis, S. Einaudi, A. Testa, B. Karges, M. Peter, M. Viemann, J. Grotzinger, W. G. Sippell, et al. Elucidating the Underlying Molecular Pathogenesis of NR3C2 Mutants Causing Autosomal Dominant Pseudohypoaldosteronism Type 1 J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4552 - 4561. [Abstract] [Full Text] [PDF]

				F. L. Fernandes-Rosa, M. de Castro, A. C. Latronico, W. G. Sippell, F. G. Riepe, and S. R. Antonini Recurrence of the R947X Mutation in Unrelated Families with Autosomal Dominant Pseudohypoaldosteronism Type 1: Evidence for a Mutational Hot Spot in the Mineralocorticoid Receptor Gene J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3671 - 3675. [Abstract] [Full Text] [PDF]

				D. S. Geller, J. Zhang, M.-C. Zennaro, A. Vallo-Boado, J. Rodriguez-Soriano, L. Furu, R. Haws, D. Metzger, B. Botelho, L. Karaviti, et al. Autosomal Dominant Pseudohypoaldosteronism Type 1: Mechanisms, Evidence for Neonatal Lethality, and Phenotypic Expression in Adults J. Am. Soc. Nephrol., May 1, 2006; 17(5): 1429 - 1436. [Abstract] [Full Text] [PDF]

				P. Sartorato, F. Cluzeaud, J. Fagart, S. Viengchareun, M. Lombes, and M.-C. Zennaro New Naturally Occurring Missense Mutations of the Human Mineralocorticoid Receptor Disclose Important Residues Involved in Dynamic Interactions with Deoxyribonucleic Acid, Intracellular Trafficking, and Ligand Binding Mol. Endocrinol., September 1, 2004; 18(9): 2151 - 2165. [Abstract] [Full Text] [PDF]

				W. Y. Li, C. L. Huey, and A. S. L. Yu Expression of claudin-7 and -8 along the mouse nephron Am J Physiol Renal Physiol, June 1, 2004; 286(6): F1063 - F1071. [Abstract] [Full Text] [PDF]

				F. G. Riepe, N. Krone, M. Morlot, M. Peter, W. G. Sippell, and C.-J. Partsch Autosomal-Dominant Pseudohypoaldosteronism Type 1 in a Turkish Family Is Associated with a Novel Nonsense Mutation in the Human Mineralocorticoid Receptor Gene J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2150 - 2152. [Abstract] [Full Text] [PDF]

				A.-M. Nystrom, M.-L. Bondeson, N. Skanke, J. Martensson, B. Stromberg, J. Gustafsson, and G. Anneren A Novel Nonsense Mutation of the Mineralocorticoid Receptor Gene in a Swedish Family with Pseudohypoaldosteronism Type I (PHA1) J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 227 - 231. [Abstract] [Full Text] [PDF]

				P. Sartorato, A.-L. Lapeyraque, D. Armanini, U. Kuhnle, Y. Khaldi, R. Salomon, V. Abadie, E. Di Battista, A. Naselli, A. Racine, et al. Different Inactivating Mutations of the Mineralocorticoid Receptor in Fourteen Families Affected by Type I Pseudohypoaldosteronism J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2508 - 2517. [Abstract] [Full Text] [PDF]

				F. G. Riepe, N. Krone, M. Morlot, M. Ludwig, W. G. Sippell, and C.-J. Partsch Identification of a Novel Mutation in the Human Mineralocorticoid Receptor Gene in a German Family with Autosomal-Dominant Pseudohypoaldosteronism Type 1: Further Evidence for Marked Interindividual Clinical Heterogeneity J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1683 - 1686. [Abstract] [Full Text] [PDF]

				C. P. Thomas, J. Zhou, K. Z. Liu, V. E. Mick, E. MacLaughlin, and M. Knowles Systemic Pseudohypoaldosteronism from Deletion of the Promoter Region of the Human {beta} Epithelial Na+ Channel Subunit Am. J. Respir. Cell Mol. Biol., September 1, 2002; 27(3): 314 - 319. [Abstract] [Full Text] [PDF]

				O. Bonny and B. C. Rossier Disturbances of Na/K Balance: Pseudohypoaldosteronism Revisited J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2399 - 2414. [Full Text] [PDF]

				J. A. Schafer Abnormal regulation of ENaC: syndromes of salt retention and salt wasting by the collecting duct Am J Physiol Renal Physiol, August 1, 2002; 283(2): F221 - F235. [Abstract] [Full Text] [PDF]